NCT04349657View on ClinicalTrials.gov

A Study Evaluating the Endovascular Treatment of Subjects with Stenotic or Restenotic Lesions of the Common Femoral Artery with the Supera Vascular Mimetic Implant Compared to Surgical Common Femoral Artery Endarterectomy

NARecruitingINTERVENTIONAL
Enrollment

286

Participants

Timeline

Start Date

May 5, 2020

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2028

Conditions
Peripheral Arterial Disease
Interventions
DEVICE

Supera Peripheral Stent System treatment group

Percutaneous endovascular stenting with the Supera Peripheral Stent System

PROCEDURE

Endarterectomy treatment group

Surgical treatment through endarterectomy

Trial Locations (13)

1624

RECRUITING

Dijklander hospital, Hoorn

1800

RECRUITING

A.Z. Jan Portaels, Vilvoorde

1815

RECRUITING

Noordwest ziekenhuisgroep, Alkmaar

2800

NOT_YET_RECRUITING

AZ Sint-Maarten, Mechelen

2820

RECRUITING

Imelda Hospital, Bonheiden

3543

RECRUITING

St Antonius Hospital, Utrecht

3600

RECRUITING

Z.O.L., Genk

6229

RECRUITING

Maastricht UMC+, Maastricht

8500

RECRUITING

Az Groeninge, Kortrijk

9200

RECRUITING

A.Z. Sint-Blasius, Dendermonde

9300

RECRUITING

O.L.V. Hospital, Aalst

31-061

RECRUITING

Bonifraterskie Centrum Medyczne, Krakow

61-848

RECRUITING

Karol Marcinkowski Medical University, Poznan

Sponsors

Lead Sponsor

ID3 Medical
All Listed Sponsors
lead

ID3 Medical

OTHER

NCT04349657 - A Study Evaluating the Endovascular Treatment of Subjects with Stenotic or Restenotic Lesions of the Common Femoral Artery with the Supera Vascular Mimetic Implant Compared to Surgical Common Femoral Artery Endarterectomy | Biotech Hunter | Biotech Hunter